Recap: United Therapeutics Q1 Earnings

United Therapeutics UTHR reported its Q1 earnings results on Wednesday, May 3, 2023 at 06:00 AM.

Here's what investors need to know about the announcement.

United Therapeutics beat estimated earnings by 7.52%, reporting an EPS of $4.86 versus an estimate of $4.52.

Revenue was up $45.00 million from the same period last year.

Last quarter the company missed on EPS by $1.84 which was followed by a 1.89% increase in the share price the next day.

Here's a look at United Therapeutics's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	4.51	3.89	4.12	3.34
EPS Actual	2.67	4.91	2.41	5.03
Revenue Estimate	519.21M	493.20M	461.06M	420.02M
Revenue Actual	491.50M	516.00M	466.90M	461.90M

To track all earnings releases for United Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar